Christopher Martin
4Patents
2h-index
14Co-inventors
37Inventor score
Filing activity: Jul 30, 2012 → Jun 22, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9238669B2 | Oligosaccharides and oligosaccharide-protein conjugates derived from Clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools | Physics | 3 | Active |
| US9815889B2 | Antibodies for prevention and treatment of diseases caused by clostridium difficile | Human Necessities | 2 | Active |
| US10596272B2 | Vaccines against Streptococcus pneumoniae serotype 5 | Human Necessities | 2 | Active |
| US11191822B2 | Pneumococcal polysaccharide-protein conjugate composition | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.